Day Zero Diagnostics

Day Zero Diagnostics has been recognized as an Innovation Leader at LSI's Europe Emerging Medtech Summit 2024.

Jong Lee

President, CEO, & Co-founder

Day Zero Diagnostics

Rapid diagnosis of drug-resistant bacterial infections using whole genome sequencing and machine learning, to reduce the test time from days to hours

Share

LSI Alumni Innovator

Day Zero Diagnostics to announce major milestone updates at 2022 event.

Trusted By The Companies Pioneering What’s Next

  • 0-Minnetronix.png
  • 1-jnj.png
  • 2-medtronic.png
  • 3-abbott.png
  • 4-baxter.png
  • 5-mckinsey.png
  • 7-bostonscientific.png
  • 8-bd.png
  • 9-smithnephew.png
  • 10-stryker.png
  • 33m.png
  • allergan.png
  • bbraun.png
  • beckmancoulter.png
  • cardinal.png
  • depuysynthes.png
  • drager.png
  • edwardslifesciences.png
  • ethicon.png
  • ge.png
  • gore.png
  • health-advances.png
  • hospira.png
  • jlabs.png
  • kimberlyclark.png
  • merck.png
  • olympus.png
  • orthofix.png
  • philips.png
  • sanofigenzyme.png
  • tecan.png
  • teleflex.png
  • terumo.png
  • zimmerbiomet.png